azacitidine has been researched along with HIV in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Daly, MB; Greggs, WM; Kim, B; Mansky, LM; McDaniel, YZ; Patterson, SE; Roth, M; Talledge, N | 1 |
| Essigmann, JM; Fedeles, BI; Li, D; Peng, CS; Silvestre, KJ; Simi, AK; Simpson, JH; Singh, V; Tokmakoff, A | 1 |
| Clouser, CL; Mansky, LM; Patterson, SE | 1 |
| Fernandez, G; Zeichner, SL | 1 |
| Krečmerová, M; Otmar, M | 1 |
| Bagnis, C; Bréchot, C; Chapel, S; Gerolami, R; Jordier, F; Mannoni, P; Uch, R | 1 |
1 review(s) available for azacitidine and HIV
| Article | Year |
|---|---|
5-azacytosine compounds in medicinal chemistry: current stage and future perspectives.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Azacitidine; Cytosine; DNA Methylation; Drug Discovery; HIV; HIV Infections; Humans; Neoplasms | 2012 |
5 other study(ies) available for azacitidine and HIV
| Article | Year |
|---|---|
Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen.
Topics: Animals; Antiviral Agents; Azacitidine; Cats; Cytidine Triphosphate; HIV; HIV Infections; Humans; Leukemia Virus, Feline; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mutagenesis; Mutagens; Mutation; Retroviridae Infections; Tumor Virus Infections; Virus Replication | 2021 |
Tautomerism provides a molecular explanation for the mutagenic properties of the anti-HIV nucleoside 5-aza-5,6-dihydro-2'-deoxycytidine.
Topics: Anti-HIV Agents; Azacitidine; Bacteriophage M13; Base Pairing; Deoxycytidine; Genome, Viral; HIV; Humans; Isomerism; Magnetic Resonance Spectroscopy; Models, Chemical; Mutagens; Spectrophotometry, Infrared; Virus Replication | 2014 |
Exploiting drug repositioning for discovery of a novel HIV combination therapy.
Topics: Anti-HIV Agents; Azacitidine; Decitabine; Deoxycytidine; Drug Interactions; Drug Therapy, Combination; Gemcitabine; HIV; HIV Infections; Humans; Mutation | 2010 |
Cell line-dependent variability in HIV activation employing DNMT inhibitors.
Topics: Azacitidine; Decitabine; DNA Modification Methylases; Enzyme Inhibitors; Genes, Reporter; Green Fluorescent Proteins; HIV; Humans; Hydroxamic Acids; Jurkat Cells; Tumor Necrosis Factor-alpha; Virus Activation; Virus Latency | 2010 |
Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors.
Topics: Azacitidine; Carcinoma, Hepatocellular; Cell Survival; Dexamethasone; Flow Cytometry; Genetic Vectors; Green Fluorescent Proteins; HIV; Humans; Interleukin-6; Ionomycin; Kinetics; Leukemia Virus, Murine; Liver Neoplasms; Luminescent Proteins; Recombinant Proteins; Tetradecanoylphorbol Acetate; Transduction, Genetic; Transgenes; Tumor Cells, Cultured | 2000 |